FierceFinanceFierceFinanceITFierceSarbox   FierceCIO
About | Sample | Privacy

Dr. Doom vs. Goldman Sachs

Tools
Tags
Nouriel Roubini
Morgan Stanley
Lloyd Blankfein
John Thain
Goldman Sachs
commercial banks
Capital Injections

Nouriel Roubini--the most famous of cosmic bears these days, the man the New York Times dubbed Dr. Doom--doesn't think much of Goldman Sachs' chances of survival. In an opinion piece in Forbes, he argues that Goldman Sachs' and Morgan Stanley's days are numbered, even with their recent capital injections. "If John Mack and Lloyd Blankfein don't want to end up like Richard Fuld, they should do a John Thain today and merge as fast as they can with other large commercial banks." That says it all. He doubts that the world really buys their "conversion" to commercial banks, not without the capital structure of a commercial bank. He errs, however, when he asserts that most of Goldman's business lines are losing money, Goldman argues in its rebuttal. The firm says that Roubini needs to differentiate among specific firms and that Goldman is poised to survive. Roubini, of course, famously predicted that every major independent broker deal would fail. He's been more than half right so far. At this point, Morgan Stanley would appear to be in more danger and more likely to enter a bailout merger.

For more:
- here's the column
- here's the rebuttal

Related Articles:
Warren Buffett rides to Goldman Sachs' rescue
More on the future of Goldman and Morgan
Morgan Stanley, Goldman Sachs now commercial banks

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 20 + 40?
To combat spam, please solve the math question above.